A systematic review of targeted agents for non-small cell lung cancer
HH Vestergaard, MR Christensen, UN Lassen - Acta oncologica, 2018 - Taylor & Francis
Background: advanced-stage non-small cell lung cancer (NSCLC) is characterized by
having limited treatment options and thus a poor prognosis. However, new treatment …
having limited treatment options and thus a poor prognosis. However, new treatment …
A systematic review of targeted agents for non-small cell lung cancer
HH Vestergaard, MR Christensen… - Acta oncologica …, 2018 - pubmed.ncbi.nlm.nih.gov
Background advanced-stage non-small cell lung cancer (NSCLC) is characterized by
having limited treatment options and thus a poor prognosis. However, new treatment …
having limited treatment options and thus a poor prognosis. However, new treatment …
A systematic review of targeted agents for non-small cell lung cancer
HH Vestergaard, MR Christensen, UN Lassen - Acta Oncologica, 2018 - vbn.aau.dk
Background: advanced-stage non-small cell lung cancer (NSCLC) is characterized by
having limited treatment options and thus a poor prognosis. However, new treatment …
having limited treatment options and thus a poor prognosis. However, new treatment …
A systematic review of targeted agents for non-small cell lung cancer
HH Vestergaard, MR Christensen… - Acta oncologica, 2018 - research.regionh.dk
BACKGROUND: advanced-stage non-small cell lung cancer (NSCLC) is characterized by
having limited treatment options and thus a poor prognosis. However, new treatment …
having limited treatment options and thus a poor prognosis. However, new treatment …
A systematic review of targeted agents for non-small cell lung cancer.
HH Vestergaard, MR Christensen… - Acta …, 2018 - search.ebscohost.com
Background: advanced-stage non-small cell lung cancer (NSCLC) is characterized by
having limited treatment options and thus a poor prognosis. However, new treatment …
having limited treatment options and thus a poor prognosis. However, new treatment …
A systematic review of targeted agents for non-small cell lung cancer.
HH Vestergaard, MR Christensen… - Acta Oncologica …, 2017 - europepmc.org
Background advanced-stage non-small cell lung cancer (NSCLC) is characterized by
having limited treatment options and thus a poor prognosis. However, new treatment …
having limited treatment options and thus a poor prognosis. However, new treatment …
[引用][C] A systematic review of targeted agents for non-small cell lung cancer
HH Vestergaard, MR Christensen, UN Lassen - Acta Oncologica, 2017 - cir.nii.ac.jp
A systematic review of targeted agents for non-small cell lung cancer | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
[引用][C] A systematic review of targeted agents for non-small cell lung cancer
HH Vestergaard, MR Christensen, UN Lassen - vbn.aau.dk
A systematic review of targeted agents for non-small cell lung cancer – Datasets — Aalborg
University's Research Portal Skip to main navigation Skip to search Skip to main content …
University's Research Portal Skip to main navigation Skip to search Skip to main content …